Patients Are Praising The Uconn Health Portal For Its Simple Design
参考文献：A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction.
UConn Health Goes Red - UConn Today
